0 items USD 0.00Search
Your search for "globaldata chronic myelocytic leukemia cml chronic myeloid leukemia global clinical trials review h1" gave back 763000 results.
Inhibition of dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine synthesis pathway, was recently reported to induce...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
The global Hematological Malignancies market size was valued at US$ 29080 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Arsenic trioxide injection is a medication used in the treatment of a specific type of leukemia called acute promyelocytic leukemia (APL), which is a...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Inhibition of dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine synthesis pathway, was recently reported to induce...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML),...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Markers are broadly categorized as biomarkers or molecular markers and biochemical markers. Biomarker, also known as biological marker is commonly...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Markers are broadly categorized as biomarkers or molecular markers and biochemical markers. Biomarker, also known as biological marker is commonly...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Bendamustine hydrochloride injection is a cytotoxic drug used to treat chronic lymphoblastic leukemia and non Hodgkin's lymphoma. The global...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
The global Harringtonine market size was valued at US$ million in 2023. With growing demand in downstream market, the Harringtonine is forecast to a...
Catalog:
LPI
March 2024
Price: USD 3,660.00
